InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Discover the detailed record of transactions filed by Fridriksdottir Hafrun, Vice-Président Exécutif. Insider active across 1 companies, notably Teva Pharmaceutical Industries Ltd. In total, 9 filings have been recorded. Total volume traded: €1.9m. The latest transaction was disclosed on 17 May 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations9 total
€1m130,000 shares@ €7.78920.0028% mcap54.0% of flow
Ordinary Shares
SEC:0001209191-22-030308:0·
51,488 shares
Ordinary Shares
SEC:0001209191-22-017046:0·
21,682 shares
Ordinary Shares
SEC:0001209191-22-014469:0·
16,121 shares
Ordinary Shares
SEC:0001209191-22-008415·
16,121 shares
Ordinary Shares
SEC:0001209191-22-008415:0·
€431,63650,860 shares@ €8.48680.0012% mcap100.0% of flow
Ordinary Shares
SEC:0001209191-21-051075·
€431,63650,860 shares@ €8.48680.0012% mcap23.0% of flow
Ordinary Shares
SEC:0001209191-21-051075:0·
37,884 shares
Ordinary Shares
SEC:0001209191-21-032252·
37,884 shares
Ordinary Shares
SEC:0001209191-21-032252:0·
9 of 9 declarations
About Fridriksdottir Hafrun
Hafrun Fridriksdottir is Executive Vice President, Global R&D at Teva Pharmaceutical Industries Ltd. She plays a key role in innovation and the development of new products, contributing to the company's mission to provide health solutions.
